checkAd
    Collegium Pharmaceutical Aktie
    36,42
     
    USD
    +1,62 %
    +0,58 USD
    Letzter Kurs 27.04.24 Nasdaq
    36,37
     
    USD
    700 STK
    Geldkurs 26.04.24
    36,43
     
    USD
    100 STK
    Briefkurs 26.04.24
    ISIN: US19459J1043 · WKN: A14SUV · SYM: COLL · USA

    Neueste Nachrichten

    Collegium to Report First Quarter 2024 Financial Results on May 9, 2024
    25.04.24 · globenewswire · Collegium Pharmaceutical
    Collegium Pharmaceutical, Inc. Announces Redemption of Outstanding 2.625% Convertible Senior Notes Due 2026
    11.04.24 · globenewswire · Collegium Pharmaceutical
    Collegium to Participate in 23rd Annual Needham Virtual Healthcare Conference
    03.04.24 · globenewswire · Collegium Pharmaceutical
    Collegium Reports Record Fourth Quarter and Full-Year 2023 Financial Results
    22.02.24 · globenewswire · Collegium Pharmaceutical
    Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024
    08.02.24 · globenewswire · Collegium Pharmaceutical
    Collegium Provides 2024 Financial Guidance
    03.01.24 · globenewswire · Collegium Pharmaceutical
    Appeals Court Upholds PTAB’s Finding of Invalidity of Purdue’s 961 Patent
    27.11.23 · globenewswire · Collegium Pharmaceutical
    Collegium Announces $25 Million Accelerated Share Repurchase Program
    09.11.23 · globenewswire · Collegium Pharmaceutical
    Collegium to Participate in Upcoming Investor Conferences
    08.11.23 · globenewswire · Collegium Pharmaceutical
    Collegium to Report Third Quarter 2023 Financial Results on November 7, 2023
    24.10.23 · globenewswire · Collegium Pharmaceutical
    Collegium Announces 10 Poster Presentations at PAINWeek Conference 2023
    28.08.23 · globenewswire · Collegium Pharmaceutical
    Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026
    24.08.23 · globenewswire · Collegium Pharmaceutical